Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Obstructive Lung Diseases

  Free Subscription


Articles published in Respir Res

Retrieve available abstracts of 66 articles:
HTML format
Text format



Single Articles


    April 2017
  1. JUNG KH, Torrone D, Lovinsky-Desir S, Perzanowski M, et al
    Short-term exposure to PM2.5 and vanadium and changes in asthma gene DNA methylation and lung function decrements among urban children.
    Respir Res. 2017;18:63.
    PubMed     Text format     Abstract available


  2. CRUICKSHANK-QUINN C, Armstrong M, Powell R, Gomez J, et al
    Determining the presence of asthma-related molecules and salivary contamination in exhaled breath condensate.
    Respir Res. 2017;18:57.
    PubMed     Text format     Abstract available


  3. BAKER K, Raemdonck K, Snelgrove RJ, Belvisi MG, et al
    Characterisation of a murine model of the late asthmatic response.
    Respir Res. 2017;18:55.
    PubMed     Text format     Abstract available


    March 2017
  4. NATARAJAN S, Free RC, Bradding P, McGarvey L, et al
    The relationship between the Leicester cough questionnaire, eosinophilic airway inflammation and asthma patient related outcomes in severe adult asthma.
    Respir Res. 2017;18:44.
    PubMed     Text format     Abstract available


    February 2017
  5. SEYS SF, Scheers H, Van den Brande P, Marijsse G, et al
    Cluster analysis of sputum cytokine-high profiles reveals diversity in T(h)2-high asthma patients.
    Respir Res. 2017;18:39.
    PubMed     Text format     Abstract available


  6. BOULAY ME, Henry C, Bosse Y, Boulet LP, et al
    Acute effects of nicotine-free and flavour-free electronic cigarette use on lung functions in healthy and asthmatic individuals.
    Respir Res. 2017;18:33.
    PubMed     Text format     Abstract available


    January 2017
  7. MAKIKYRO EM, Jaakkola MS, Jaakkola JJ
    Subtypes of asthma based on asthma control and severity: a latent class analysis.
    Respir Res. 2017;18:24.
    PubMed     Text format     Abstract available


  8. FUJII U, Miyahara N, Taniguchi A, Oda N, et al
    Effect of a retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness in a murine model of asthma.
    Respir Res. 2017;18:23.
    PubMed     Text format     Abstract available


  9. BIHLET AR, Karsdal MA, Sand JM, Leeming DJ, et al
    Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD.
    Respir Res. 2017;18:22.
    PubMed     Text format     Abstract available


  10. GREEN CE, Turner AM
    The role of the endothelium in asthma and chronic obstructive pulmonary disease (COPD).
    Respir Res. 2017;18:20.
    PubMed     Text format     Abstract available


  11. TAYEL SI, El-Hefnway SM, Abd El Gayed EM, Abdelaal GA, et al
    Association of stem cell factor gene expression with severity and atopic state in patients with bronchial asthma.
    Respir Res. 2017;18:21.
    PubMed     Text format     Abstract available


  12. AUGUSTO LS, Silva GC, Pinho JF, Aires RD, et al
    Vascular function in asthmatic children and adolescents.
    Respir Res. 2017;18:17.
    PubMed     Text format     Abstract available


  13. O'NEILL B, McDonough SM, Wilson JJ, Bradbury I, et al
    Comparing accelerometer, pedometer and a questionnaire for measuring physical activity in bronchiectasis: a validity and feasibility study?
    Respir Res. 2017;18:16.
    PubMed     Text format     Abstract available


  14. KIM SH, Pei QM, Jiang P, Yang M, et al
    Effect of active vitamin D3 on VEGF-induced ADAM33 expression and proliferation in human airway smooth muscle cells: implications for asthma treatment.
    Respir Res. 2017;18:7.
    PubMed     Text format     Abstract available


    December 2016
  15. LOZA MJ, Djukanovic R, Chung KF, Horowitz D, et al
    Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study.
    Respir Res. 2016;17:165.
    PubMed     Text format     Abstract available


  16. SULLIVAN A, Hunt E, MacSharry J, Murphy DM, et al
    'The Microbiome and the Pathophysiology of Asthma'.
    Respir Res. 2016;17:163.
    PubMed     Text format     Abstract available


    November 2016
  17. O'BYRNE PM, Jacques L, Goldfrad C, Kwon N, et al
    Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma.
    Respir Res. 2016;17:157.
    PubMed     Text format     Abstract available


  18. KRAEMER R, Smith HJ, Sigrist T, Giger G, et al
    Diagnostic accuracy of methacholine challenge tests assessing airway hyperreactivity in asthmatic patients - a multifunctional approach.
    Respir Res. 2016;17:154.
    PubMed     Text format     Abstract available


  19. WANG M, Gao P, Wu X, Chen Y, et al
    Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma.
    Respir Res. 2016;17:153.
    PubMed     Text format     Abstract available


  20. FRANZEN S, Janson C, Larsson K, Petzold M, et al
    Evaluation of the use of Swedish integrated electronic health records and register health care data as support clinical trials in severe asthma: the PACEHR study.
    Respir Res. 2016;17:152.
    PubMed     Text format     Abstract available


  21. TERASHITA T, Kobayashi K, Nagano T, Kawa Y, et al
    Administration of JTE013 abrogates experimental asthma by regulating proinflammatory cytokine production from bronchial epithelial cells.
    Respir Res. 2016;17:146.
    PubMed     Text format     Abstract available


    October 2016
  22. TAILLE C, Grootenboer-Mignot S, Estellat C, Roy C, et al
    Perip7lakin is a target for autoimmunity in asthma.
    Respir Res. 2016;17:126.
    PubMed     Text format     Abstract available


  23. SOUTHWORTH T, Plumb J, Gupta V, Pearson J, et al
    Anti-inflammatory potential of PI3Kdelta and JAK inhibitors in asthma patients.
    Respir Res. 2016;17:124.
    PubMed     Text format     Abstract available


    April 2016
  24. HOONHORST SJ, Lo Tam Loi AT, Pouwels SD, Faiz A, et al
    Advanced glycation endproducts and their receptor in different body compartments in COPD.
    Respir Res. 2016;17:46.
    PubMed     Text format     Abstract available


  25. MARTIN AL, Marvel J, Fahrbach K, Cadarette SM, et al
    The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysis.
    Respir Res. 2016;17:40.
    PubMed     Text format     Abstract available


  26. HIMES BE, Weitzman ER
    Innovations in health information technologies for chronic pulmonary diseases.
    Respir Res. 2016;17:38.
    PubMed     Text format     Abstract available


  27. HADEBE S, Kirstein F, Fierens K, Redelinghuys P, et al
    beta-Glucan exacerbates allergic airway responses to house dust mite allergen.
    Respir Res. 2016;17:35.
    PubMed     Text format     Abstract available


    March 2016
  28. HAMPSON JA, Stockley RA, Turner AM
    Free light chains: potential biomarker and predictor of mortality in alpha-1-antitrypsin deficiency and usual COPD.
    Respir Res. 2016;17:34.
    PubMed     Text format     Abstract available


  29. KOBAYASHI Y, Ito K, Kanda A, Tomoda K, et al
    Protein tyrosine phosphatase PTP-RR regulates corticosteroid sensitivity.
    Respir Res. 2016;17:30.
    PubMed     Text format     Abstract available


  30. LAI T, Wu D, Chen M, Cao C, et al
    YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling.
    Respir Res. 2016;17:31.
    PubMed     Text format     Abstract available


  31. CALVERLEY PM, Rennard SI, Clerisme-Beaty E, Metzdorf N, et al
    Effect of tiotropium on night-time awakening and daily rescue medication use in patients with COPD.
    Respir Res. 2016;17:27.
    PubMed     Text format     Abstract available


  32. FILEP A, Fodor GH, Kun-Szabo F, Tiszlavicz L, et al
    Exposure to urban PM1 in rats: development of bronchial inflammation and airway hyperresponsiveness.
    Respir Res. 2016;17:26.
    PubMed     Text format     Abstract available


    February 2016
  33. SOHAL SS
    Endothelial to mesenchymal transition (EndMT): an active process in Chronic Obstructive Pulmonary Disease (COPD)?
    Respir Res. 2016;17:20.
    PubMed     Text format     Abstract available


  34. LUO J, Wang K, Liu D, Liang BM, et al
    Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis.
    Respir Res. 2016;17:18.
    PubMed     Text format     Abstract available


    January 2016
  35. GIANNAKAKI S, Politi L, Antonogiannaki EM, Spanakis N, et al
    Absence of human rhinovirus and respiratory syncytial virus from bronchoalveolar lavage and bronchial biopsies of selected patients with stable chronic obstructive pulmonary disease.
    Respir Res. 2016;17:11.
    PubMed     Text format     Abstract available


  36. GRUNDY S, Plumb J, Kaur M, Ray D, et al
    Additive anti-inflammatory effects of corticosteroids and phosphodiesterase-4 inhibitors in COPD CD8 cells.
    Respir Res. 2016;17:9.
    PubMed     Text format     Abstract available


  37. ABE K, Sugiura H, Hashimoto Y, Ichikawa T, et al
    Possible role of Kruppel-like factor 5 in the remodeling of small airways and pulmonary vessels in chronic obstructive pulmonary disease.
    Respir Res. 2016;17:7.
    PubMed     Text format     Abstract available


  38. SINGH JA, Yu S
    Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS).
    Respir Res. 2016;17:1.
    PubMed     Text format     Abstract available


  39. SALTER BM, Oliveria JP, Nusca G, Smith SG, et al
    IL-25 and IL-33 induce Type 2 inflammation in basophils from subjects with allergic asthma.
    Respir Res. 2016;17:5.
    PubMed     Text format     Abstract available


  40. KISTEMAKER LE, Bos IS, Menzen MH, Maarsingh H, et al
    Combination therapy of tiotropium and ciclesonide attenuates airway inflammation and remodeling in a guinea pig model of chronic asthma.
    Respir Res. 2016;17:13.
    PubMed     Text format     Abstract available


  41. SHIOBARA T, Chibana K, Watanabe T, Arai R, et al
    Dipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constitutive cells.
    Respir Res. 2016;17:28.
    PubMed     Text format     Abstract available


  42. HARRIS JM, Maciuca R, Bradley MS, Cabanski CR, et al
    A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma.
    Respir Res. 2016;17:29.
    PubMed     Text format     Abstract available


  43. KONRADSEN JR, Nordlund B, Levanen B, Hedlin G, et al
    The cytokine interleukin-26 as a biomarker in pediatric asthma.
    Respir Res. 2016;17:32.
    PubMed     Text format     Abstract available


  44. OLIVER AJ, Covar RA, Goldfrad CH, Klein RM, et al
    Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy.
    Respir Res. 2016;17:37.
    PubMed     Text format     Abstract available


  45. CRESPO-LESSMANN A, Mateus E, Vidal S, Ramos-Barbon D, et al
    Expression of toll-like receptors 2 and 4 in subjects with asthma by total serum IgE level.
    Respir Res. 2016;17:41.
    PubMed     Text format     Abstract available


  46. RAEMDONCK K, Baker K, Dale N, Dubuis E, et al
    CD4(+) and CD8(+) T cells play a central role in a HDM driven model of allergic asthma.
    Respir Res. 2016;17:45.
    PubMed     Text format     Abstract available


  47. SILKOFF PE, Laviolette M, Singh D, FitzGerald JM, et al
    Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study.
    Respir Res. 2016;17:43.
    PubMed     Text format     Abstract available


  48. BRAIDO F, Brusselle G, Guastalla D, Ingrassia E, et al
    Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study.
    Respir Res. 2016;17:51.
    PubMed     Text format     Abstract available


  49. BAKER K, Raemdonck K, Dekkak B, Snelgrove RJ, et al
    Role of the ion channel, transient receptor potential cation channel subfamily V member 1 (TRPV1), in allergic asthma.
    Respir Res. 2016;17:67.
    PubMed     Text format     Abstract available


  50. MEBRATU YA, Smith KR, Agga GE, Tesfaigzi Y, et al
    Inflammation and emphysema in cigarette smoke-exposed mice when instilled with poly (I:C) or infected with influenza A or respiratory syncytial viruses.
    Respir Res. 2016;17:75.
    PubMed     Text format     Abstract available


  51. NASSER S
    An imperfect "PAST" Lessons learned from the National Review of Asthma Deaths (NRAD) UK.
    Respir Res. 2016;17:87.
    PubMed     Text format     Abstract available


  52. OSTRIDGE K, Williams N, Kim V, Harden S, et al
    Distinct emphysema subtypes defined by quantitative CT analysis are associated with specific pulmonary matrix metalloproteinases.
    Respir Res. 2016;17:92.
    PubMed     Text format     Abstract available


  53. EHTESHAMI-AFSHAR S, FitzGerald JM, Carlsten C, Tavakoli H, et al
    The impact of comorbidities on productivity loss in asthma patients.
    Respir Res. 2016;17:106.
    PubMed     Text format     Abstract available


  54. XU D, Wang Y, Chen Z, Li S, et al
    Prevalence and risk factors for asthma among children aged 0-14 years in Hangzhou: a cross-sectional survey.
    Respir Res. 2016;17:122.
    PubMed     Text format     Abstract available


  55. MOHEIMANI F, Hsu AC, Reid AT, Williams T, et al
    The genetic and epigenetic landscapes of the epithelium in asthma.
    Respir Res. 2016;17:119.
    PubMed     Text format     Abstract available


    January 2015
  56. SILKOFF PE, Strambu I, Laviolette M, Singh D, et al
    Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.
    Respir Res. 2015;16:142.
    PubMed     Text format     Abstract available


  57. DIXON AE, Subramanian M, DeSarno M, Black K, et al
    A pilot randomized controlled trial of pioglitazone for the treatment of poorly controlled asthma in obesity.
    Respir Res. 2015;16:143.
    PubMed     Text format     Abstract available


  58. KAI Y, Tomoda K, Yoneyama H, Yoshikawa M, et al
    RNA interference targeting carbohydrate sulfotransferase 3 diminishes macrophage accumulation, inhibits MMP-9 expression and promotes lung recovery in murine pulmonary emphysema.
    Respir Res. 2015;16:146.
    PubMed     Text format     Abstract available


  59. WIECZFINSKA J, Kacprzak D, Pospiech K, Sokolowska M, et al
    The whole - genome expression analysis of peripheral blood mononuclear cells from aspirin sensitive asthmatics versus aspirin tolerant patients and healthy donors after in vitro aspirin challenge.
    Respir Res. 2015;16:147.
    PubMed     Text format     Abstract available


  60. NISHIOKA M, Venkatesan N, Dessalle K, Mogas A, et al
    Fibroblast-epithelial cell interactions drive epithelial-mesenchymal transition differently in cells from normal and COPD patients.
    Respir Res. 2015;16:72.
    PubMed     Text format     Abstract available


  61. ALAHMARI AD, Mackay AJ, Patel AR, Kowlessar BS, et al
    Influence of weather and atmospheric pollution on physical activity in patients with COPD.
    Respir Res. 2015;16:71.
    PubMed     Text format     Abstract available


  62. DEVILLIER P, Garrigue E, D'Auzers G, Monjotin N, et al
    V0162 a new long-acting bronchodilator for treatment of chronic obstructive lung diseases: preclinical and clinical results.
    Respir Res. 2015;16:68.
    PubMed     Text format     Abstract available


  63. PATEL N, Belcher J, Thorpe G, Forsyth NR, et al
    Measurement of C-reactive protein, procalcitonin and neutrophil elastase in saliva of COPD patients and healthy controls: correlation to self-reported wellbeing parameters.
    Respir Res. 2015;16:62.
    PubMed     Text format     Abstract available


  64. GRABCANOVIC-MUSIJA F, Obermayer A, Stoiber W, Krautgartner WD, et al
    Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation.
    Respir Res. 2015;16:59.
    PubMed     Text format     Abstract available


  65. SHERIDAN JA, Zago M, Nair P, Li PZ, et al
    Decreased expression of the NF-kappaB family member RelB in lung fibroblasts from Smokers with and without COPD potentiates cigarette smoke-induced COX-2 expression.
    Respir Res. 2015;16:54.
    PubMed     Text format     Abstract available


  66. PINTO LM, Alghamdi M, Benedetti A, Zaihra T, et al
    Derivation and validation of clinical phenotypes for COPD: a systematic review.
    Respir Res. 2015;16:50.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: